In triple-negative breast cancer, tumors with high levels of infiltrating CD8+ T cells and memory CD4+ T cells might result in a better prognosis (Matsumoto et al., 2016; Oshi et al., 2020); this is consistent with BLCA. The gene discussed is CD4; the disease is bladder transitional cell carcinoma.